PubMed

Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function.

Hasslacher C; Multinational Repaglinide Renal Study Group.

Diabetes Care. 2003 Mar;26(3):886-91.PMID: 12610054 [PubMed - indexed for MEDLINE]Related articlesFree article

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

Damsbo P, Clauson P, Marbury TC, Windfeld K.

Diabetes Care. 1999 May;22(5):789-94.PMID: 10332683 [PubMed - indexed for MEDLINE]Related articlesFree article

Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment.

Schumacher S, Abbasi I, Weise D, Hatorp V, Sattler K, Sieber J, Hasslacher C.

Eur J Clin Pharmacol. 2001 May;57(2):147-52.PMID: 11417447 [PubMed - indexed for MEDLINE]Related articles

Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.

Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N, Hale PM; Repaglinide/Rosiglitazone Study Group.

Diabet Med. 2004 Apr;21(4):329-35.PMID: 15049934 [PubMed - indexed for MEDLINE]Related articles

Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.

Gerstein HC, Garon J, Joyce C, Rolfe A, Walter CM.

Diabet Med. 2004 Nov;21(11):1200-3.PMID: 15498086 [PubMed - indexed for MEDLINE]Related articles

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study.

Jovanovic L, Dailey G 3rd, Huang WC, Strange P, Goldstein BJ.

J Clin Pharmacol. 2000 Jan;40(1):49-57.PMID: 10631622 [PubMed - indexed for MEDLINE]Related articles

Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes.

Moses RG, Gomis R, Frandsen KB, Schlienger JL, Dedov I.

Diabetes Care. 2001 Jan;24(1):11-5.PMID: 11194214 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group.

Diabetes Care. 2003 Jul;26(7):2063-8. Erratum in: Diabetes Care. 2003 Sep;26(9):2708. PMID: 12832314 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.

Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N, Hale PM; Repaglinide Versus Nateglinide Comparison Study Group.

Diabetes Care. 2004 Jun;27(6):1265-70.PMID: 15161773 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes.

Kølendorf K, Eriksson J, Birkeland KI, Kjellström T, Hreidarsson AB.

Diabetes Res Clin Pract. 2004 Apr;64(1):33-40.PMID: 15036825 [PubMed - indexed for MEDLINE]Related articles

A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.

Goldberg RB, Einhorn D, Lucas CP, Rendell MS, Damsbo P, Huang WC, Strange P, Brodows RG.

Diabetes Care. 1998 Nov;21(11):1897-903.PMID: 9802740 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.

Madsbad S, Kilhovd B, Lager I, Mustajoki P, Dejgaard A; Scandinavian Repaglinide Group.

Diabet Med. 2001 May;18(5):395-401.PMID: 11472451 [PubMed - indexed for MEDLINE]Related articles

The efficacy of repaglinide monotherapy and in combination with metformin in Indonesian type 2 diabetes mellitus patients.

Soegondo S, Subekti I, Luthariana L.

Acta Med Indones. 2004 Jul-Sep;36(3):142-7.PMID: 15557683 [PubMed - indexed for MEDLINE]Related articles

[Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients]

Landgraf R.

MMW Fortschr Med. 2000 Jul 20;142(28-29):29-30. German. PMID: 10959157 [PubMed - indexed for MEDLINE]Related articles

Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide.

Schmitz O, Lund S, Andersen PH, Jønler M, Pørksen N.

Diabetes Care. 2002 Feb;25(2):342-6.PMID: 11815507 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.

Jovanovic L, Hassman DR, Gooch B, Jain R, Greco S, Khutoryansky N, Hale PM.

Diabetes Res Clin Pract. 2004 Feb;63(2):127-34.PMID: 14739053 [PubMed - indexed for MEDLINE]Related articles

Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.

Mafauzy M.

Diabetes Res Clin Pract. 2002 Oct;58(1):45-53.PMID: 12161056 [PubMed - indexed for MEDLINE]Related articles

Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.

Johansen OE, Birkeland KI.

Am J Cardiovasc Drugs. 2007;7(5):319-35. Review.PMID: 17953471 [PubMed - indexed for MEDLINE]Related articles

Repaglinide administration improves brachial reactivity in type 2 diabetic patients.

Manzella D, Grella R, Abbatecola AM, Paolisso G.

Diabetes Care. 2005 Feb;28(2):366-71.PMID: 15677794 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles